The Glycated Albumin (GA) to HbA1c Ratio Reflects Shorter‐Term Glycemic Control than GA: Analysis of Patients with Fulminant Type 1 Diabetes
Authors:
- 8 July 2016
- journal article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 31 (1)
Abstract
Background: Glycated albumin (GA) reflects shorter‐term glycemic control than HbA1c. We have reported that HbA1c is paradoxically increased in diabetic patients whose glycemic control deteriorated before ameliorating. In this study, we analyzed paradoxical increases of glycemic control indicators after treatment in patients with fulminant type 1 diabetes (FT1D). We also investigated whether the GA/HbA1c ratio may reflect shorter‐term glycemic control than GA.Methods: Five FT1D patients whose post‐treatment HbA1c and GA levels were measured were enrolled. We also used a formula to estimate HbA1c and GA from the fictitious models of changes in plasma glucose in FT1D patients. In this model, the periods during which HbA1c, GA, and the GA/HbA1c ratio were higher than at the first visit were compared. In addition, the half‐life for the GA/HbA1c ratio was calculated in accordance with the half‐lives for HbA1c and GA (36 and 14 days, respectively).Results: In all FT1D patients, HbA1c levels 2–4 weeks after treatment were increased, with three patients (60%) experiencing an increase of GA levels. In contrast, an increase of the GA/HbA1c ratio was observed in only one patient. In all of the different models of changes in plasma glucose in FT1D patients, the length of time during which the values were higher than at the first visit was in the order of HbA1c > GA > GA/HbA1c ratio. The half‐life for the GA/HbA1c ratio was 9 days, shorter than GA.Conclusions: These findings suggest that the GA/HbA1c ratio reflects shorter‐term glycemic control than GA.Keywords
This publication has 13 references indexed in Scilit:
- Patients who showed paradoxical increase in HbA1c levels after intensification of diabetes treatmentClinical Biochemistry, 2015
- Glycated albumin is not significantly correlated with body mass index in patients with acute-onset type 1 diabetesClinica Chimica Acta, 2015
- Glycated albumin; clinical usefulnessClinica Chimica Acta, 2014
- Calculation of HbA1c and glycated albumin from serially measured self-monitored blood glucose in patients with type 1 diabetes mellitusClinica Chimica Acta, 2013
- International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program valuesDiabetology International, 2012
- International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program valuesJournal of Diabetes Investigation, 2012
- Study of glycated amino acid elimination reaction for an improved enzymatic glycated albumin measurement methodClinica Chimica Acta, 2004
- A case suspected of diabetes mellitus characterized by rapid onset and absence of diabetes-related antibodiesJuntendo Medical Journal, 2003
- A Novel Subtype of Type 1 Diabetes Mellitus Characterized by a Rapid Onset and an Absence of Diabetes-Related AntibodiesNew England Journal of Medicine, 2000
- Kinetics of HbA1c, Glycated Albumin, and Fructosamine and Analysis of Their Weight Functions Against Preceding Plasma Glucose LevelDiabetes Care, 1995